Bought
Maintained
Sold
Other funds holding CHE
EIP
Aviva's CHE Position: Q2 2026 in Review
Aviva reduced its Chemed (CHE) stake by 6.5% in Q2 2026, selling an estimated $29.4K and leaving 1,009 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #730.
Aviva first reported a position in CHE in Q4 2019 and has held it in 26 quarters since. The position peaked at $3.75M in Q1 2020. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.
- Aviva held 1,009 shares of Chemed worth $470K as of Q2 2026.
- Aviva sold 70 Chemed shares in Q2 2026, an estimated $29.4K.
- Chemed made up ﹤0.01% of Aviva's portfolio in Q2 2026, its #730 holding.
- Aviva first reported a position in Chemed in Q4 2019 and has held it in 26 quarters since.
- Aviva's Chemed position peaked at $3.75M in Q1 2020.
- 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.
Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.